AI assistant
Dhanuka Agritech Ltd. — Capital/Financing Update 2024
Nov 25, 2024
61335_rns_2024-11-25_1340e706-0869-4715-a1f9-eff2c7d92376.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
25[th] November, 2024
Corporate Relationship Department BSE Ltd.
Listing Department Corporate Relationship Department National Stock Exchange of India Limited BSE Ltd. Exchange Plaza, 1[st] Floor New Trading, Rotunda Building, Plot No. C/1, G. Block, P J Towers, Dalal Street Fort, Bandra- Kurla Complex, Mumbai- 400 001 Bandra East, Mumbai-400 051
Ref: Symbol- DHANUKA
Scrip Code: 507717
Sub: Intimation of the signing of Agreement by Dhanuka Agritech Limited (“Dhanuka”) with Bayer AG, Germany for the acquisition of active ingredients named “Iprovalicarb” and “ ” Triadimenol .
Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
To all stakeholders
Dhanuka Agritech Ltd. has signed an Agreement with Bayer AG, Germany for the acquisition of the crop protection active ingredients named “Iprovalicarb” and “Triadimenol” along with the trademark Melody for Iprovalicarb. This Agreement signed by Dhanuka is subject to completion of certain closing actions. This acquisition will help Dhanuka to expand its business in India and in overseas markets and with this Dhanuka will make its global presence.
The above intimation is in pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time.
Further, the detailed disclosure pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023, is enclosed as Annexure-A.
The aforementioned information shall also be available on Dhanuka's website www.dhanuka.com
For Dhanuka Agritech Limited
Digitally signed JITIN by JITIN SADANA SADANA Date: 2024.11.25 09:18:02 +05'30' Jitin Sadana Company Secretary and Compliance Officer FCS-7612
Encl: a/a
Registered & Corporate Office : Global Gateway Towers, Near Guru Dronacharya Metro Station, MG Road, Gurugram-122002, Haryana
Tel: +91-124-434-5000, Email: [email protected], Website: www.dhanuka.com CIN: L24219HR1985PLC122802
==> picture [612 x 131] intentionally omitted <==
Annexure A
| S. No | Particulars | Disclosures |
|---|---|---|
| 1. | Name of the Party with whom the agreement is entered | Bayer AG, incorporated in Germany |
| 2. | Purpose of entering into the agreement | For the acquisition of the active ingredients named “Iprovalicarb” and “Triadimenol” from an overseas entity named Bayer AG |
| 3. | Shareholding, if any, in the entity with whom the agreement is executed |
NIL |
| 4. | Significant terms of the agreement (in brief), special rights like right to appoint directors, first right to share subscription in case of issue of shares, right to restrict any change in capital structure etc. |
Dhanuka will get the rights to sell these products in India and various countries outside India. |
| 5. | Whether, the said parties are related to the promoter/ promoter group/ group companies in any manner. If yes, nature of relationship |
NO |
| 6. | Whether the transaction would fall within related party transaction? If yes, whether the same is done at “arms’ length” |
NO |
| 7. | In case of issuance of shares to the parties, details of issue price, class of shares issued |
NIL |
| 8. | Any other disclosures related to such agreements, viz. details of the nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc. |
NIL |
| 9. | In case of termination or amendment of agreement, listed entity shall disclose additional details to the stock exchange(s): i. Name of the parties to the agreement ii. Nature of the agreement iii. Date of execution of the agreement iv. Details of the amendment and impact thereof or reasons of termination and impact thereof |
NA |
Registered & Corporate Office : Global Gateway Towers, Near Guru Dronacharya Metro Station, MG Road, Gurugram-122002, Haryana Tel: +91-124-434-5000, Email: [email protected], Website: www.dhanuka.com CIN: L24219HR1985PLC122802